Research Summary
Analyzed using Evidence Intelligence™

Probiotic L. reuteri shows no effect on oral microbiome in diabetes

Key finding

Alpha diversity was analyzed with mixed-effects models, and no significant differences were observed (p > 0.05).

This study investigated the effects of Limosilactobacillus reuteri supplementation on the subgingival microbiome in diabetic patients, finding no significant alterations.

Evidence strength

Moderate confidence

Study type

RCTs

Follow-up

Medium-Term (3–12 mo)

Some Concerns bias
Last updated July 2, 2026

Quick read

Study at a glance

The essential study design details in one scan.

Population

Young Adult (19–39), Middle Aged (40-64), Male, Female, Asia-Pacific (APAC), with T2 Diabetes

Intervention

Limosilactobacillus reuteri lozenges, Placebo

Study type

RCTs

Follow-up

Medium-Term (3–12 mo)

Primary outcome

Gut microbiota diversity

Comparator

Placebo Group

Plain-language summary

What this paper says

A plain-language read of the study's main message and where it applies.

Study focus

This study investigated the effects of Limosilactobacillus reuteri supplementation on the subgingival microbiome in diabetic patients, finding no significant alterations.

Clinical relevance

Understanding the effects of probiotics like Limosilactobacillus reuteri on the microbiome is crucial for managing oral health in diabetic patients. The lack of significant changes suggests that while probiotics may not directly influence the subgingival microbiome, other factors may contribute to improvements in periodontal health.

Keep in mind

Limited sample size may affect the generalizability of findings. Short duration of the study may not capture long-term effects. Lack of significant findings limits conclusions about effectiveness.

Published in

Journal Reference

Publication details and source links for this paper.

Rocío B, Eduardo M, Cristina C, et al. Adjunctive Limosilactobacillus reuteri Supplementation Does Not Alter Subgingival Microbiome in Diabetic Patients. Journal of Oral Microbiology. 2026;18(1):2624894. doi:10.1080/20002297.2026.2624894

Save this study and add notes to your research library.

Main Effects

No significant differences in gut microbiota alpha diversity (p > 0.05).

No significant differences in beta diversity (p > 0.05).

L. reuteri was undetectable in 10 participants across all time points.

Significant reduction in probing depth observed in both groups.

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to Limosilactobacillus reuteri lozenges and Beta diversity, Gut microbiota diversity, Periodontal probing depth, and 1 more.

Primary intervention

Limosilactobacillus reuteri lozenges

Primary outcomes

  • Beta diversity
  • Gut microbiota diversity
  • Periodontal probing depth

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

4
Evidence pairs
4
Relationships
1
Evidence topics
contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 63

1

Related topics

4

Evidence pairs

14

Related studies

High relevance in at least one topic

Why it is useful

  • Contributes to 4 evidence relationships
  • Includes primary outcome data
  • Linked to 1 direct semantic evidence topic

Topic contributions

Evidence topic

Contributes evidence

Core evidence

Study findings

The primary outcomes reported in this study.

NoneNo Change

Beta diversity

Limosilactobacillus reuteri lozenges → Beta diversity

Limosilactobacillus reuteri lozenges → Beta diversity

Evidence profile

NoneNo ChangeMetabolic Health
Unlock full evidence details
NoneNo Change

Gut microbiota diversity

Limosilactobacillus reuteri lozenges → Gut microbiota diversity

Limosilactobacillus reuteri lozenges → Gut microbiota diversity

Evidence profile

NoneNo ChangeMetabolic Health
Unlock full evidence details
StrongDecrease

Periodontal probing depth

Limosilactobacillus reuteri lozenges → Periodontal probing depth

Limosilactobacillus reuteri lozenges → Periodontal probing depth

Evidence profile

StrongDecreaseClinical Outcomes
Unlock full evidence details
NoneNo Change

Relative abundance of L. reuteri

Limosilactobacillus reuteri lozenges → Relative abundance of L. reuteri

Limosilactobacillus reuteri lozenges → Relative abundance of L. reuteri

Evidence profile

NoneNo ChangeMetabolic Health
Unlock full evidence details

Unlock full evidence analysis

Create a free account to access effectiveness ratings, evidence strength and depth scores, consistency analysis, and direct links to all supporting studies.

evidence suggest

Evidence Suggest

  • Alpha and beta diversity analyses showed no significant differences (p > 0.05).
  • L. reuteri was undetectable in most participants.
  • Both groups experienced significant reductions in probing depth.
who this applies

Who this applies to

  • Diabetic patients seeking oral health improvements.
  • Individuals interested in probiotic supplementation.
keep in mind

Keep in Mind

  • Results may not apply to non-diabetic populations.
  • The study did not measure long-term effects of supplementation.
  • Findings are based on a specific probiotic strain, limiting broader applicability.
between the lines

Between the Lines

  • Limited sample size may affect the generalizability of findings.
  • Short duration of the study may not capture long-term effects.
  • Lack of significant findings limits conclusions about effectiveness.

Unlock Full Analysis

Create a free account to unlock the bias score, detailed effectiveness analysis, and clinical outcomes for this study.

Already have an account?

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

This study contributes to evidence on Probiotics and Synbiotics and Periodontal probing depth.

Related evidence relationships

Explore in Evidence Archive

This study contributes to the evidence on the following intervention-outcome relationships.

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Does Probiotics and Synbiotics improve gut microbiota diversity?

Limited Evidence

Current evidence does not show a clear benefit of Probiotics and Synbiotics for Gut Microbiota Diversity.

ConsensusScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Beta diversity

    EvidenceScore™ Limited | EvidenceScore™ 35.5 | neutral | ConsensusScore™ Unclear | 1 study

  2. 2

    Gut microbiota diversity

    EvidenceScore™ Limited | EvidenceScore™ 35.5 | neutral | ConsensusScore™ Unclear | 1 study

Why this answer: This answer is based on a small number of supporting studies and should be interpreted cautiously.

Limitations

  • Only a small number of supporting studies are available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
2 supporting studiesUpdated: Jul 2026

Does Limosilactobacillus reuteri lozenges improve periodontal probing depth?

Emerging Evidence

Limosilactobacillus reuteri lozenges appears to improve Periodontal probing depth.

ConsensusScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Periodontal probing depth

    EvidenceScore™ Emerging | EvidenceScore™ 53.0 | strong positive | ConsensusScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026

Does Limosilactobacillus reuteri lozenges improve relative abundance of l. reuteri?

Limited Evidence

Current evidence does not show a clear benefit of Limosilactobacillus reuteri lozenges for Relative abundance of L. reuteri.

ConsensusScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Relative abundance of L. reuteri

    EvidenceScore™ Limited | EvidenceScore™ 35.5 | neutral | ConsensusScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026
Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, archive views, and research summaries.

No ads. No tracking.

Focused on evidence, not advertising.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.